Preeclampsia
Conditions
Interventions
Acupuncture group:Acupuncture + labetalol
control group:labetalol
Sponsors
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1. Aged from 18 to 40 years old; 2 singleton live birth at 28-30 weeks of gestation; 3. Diagnosed with gestational hypertension; 4. sFlt-1/PLGF > 38; 5. Voluntarily participated in this study and signed informed consent
Exclusion criteria
Exclusion criteria: 1. Severe pregnancy-induced hypertension preeclampsia severe preeclampsia and eclampsia; 2. Patients with other serious primary diseases such as acute infectious diseases organic systemic diseases and malignant tumor diseases; 3. A history of hypertension and/or secondary causes of hypertension (such as underlying renal disease); 4. A fetus with a known genetic or chromosomal disorder; 5. Received acupuncture treatment within the past 3 months; 6. Received any antihypertensive drug treatment within the past 2 weeks; 7. Patients with known intentions to terminate pregnancy; 8. A history of alcohol or drug abuse within the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of preeclampsia; | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of fetal growth restriction;ncidence of small for gestational age;Gestational age at delivery;Maternal mortality rate;Mean daily morning blood pressure;Serum sFlt-1 PLGF levels and sFlt-1/PLGF ratio before and after treatment;Incidence of low birth weight infants;Stillbirth rate;Incidence of placental abruption;Neonatal 1-minute Apgar score;Blood pressure immediately before and after acupuncture; | — |
Countries
China
Contacts
Public ContactWu Linling
First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Outcome results
None listed